Subjective Experiences of Antipsychotic Treatment: A Comparison of First and Second-generation Medications among Patients with Schizophrenia

Aims: The patient’s perspective of antipsychotic treatment has been a relatively neglected area of research. Whether subjective experiences of antipsychotic treatment are better among patients on second-generation antipsychotics (SGAs), than those on first-generation antipsychotics (FGAs) has also evoked some controversy. This study attempted a longitudinal comparison of attitudes toward treatment, subjective well-being and quality of…
Read more

February 18, 2020 0